News & Updates

Lower chance of new stroke with ticagrelor vs clopidogrel in patients without ICAS

11 Nov 2023 by

A post hoc analysis of the CHANCE-2 randomized controlled trial (RCT) demonstrates that ticagrelor-aspirin combination therapy is associated with a significantly lower risk of new stroke within 90 days vs the clopidogrel-aspirin combination in Chinese CYP2C19 loss‐of‐function allele carriers with minor stroke or transient ischaemic attack (TIA) without intracranial artery stenosis (ICAS).

Lower chance of new stroke with ticagrelor vs clopidogrel in patients without ICAS

11 Nov 2023

Survey reveals an overview of patient experience with pDPN

09 Nov 2023 by

Painful diabetic peripheral neuropathy (pDPN) is the most common chronic complication of diabetes mellitus resulting from nerve damage in patients’ lower limbs.

Survey reveals an overview of patient experience with pDPN

09 Nov 2023

Brexpiprazole improves agitation in Alzheimer’s dementia

09 Nov 2023 by

A double-blind, placebo-controlled, randomized clinical trial reports significant improvement in agitation with brexpiprazole vs placebo among patients with Alzheimer’s dementia.

Brexpiprazole improves agitation in Alzheimer’s dementia

09 Nov 2023

Brain-controlled ankle prosthesis promotes natural movement, stability

08 Nov 2023 by

Neural control of a robotic ankle prosthesis appears to help its users to employ mechanisms that the body naturally uses to maintain balance and stability, including ankle movements, for better postural control, as shown in a study.

Brain-controlled ankle prosthesis promotes natural movement, stability

08 Nov 2023

Original New Drug Application Approvals by US FDA (16-31 October 2023)

08 Nov 2023

New drug applications approved by US FDA as of 16-31 October 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 October 2023)

08 Nov 2023

Retinal artery occlusion carries risk of death, adverse cardiovascular events

30 Oct 2023

Individuals with retinal artery occlusion (RAO) may be at increased risk of death, stroke, and myocardial infarction (MI) both in the short and long term, according to a study.

Retinal artery occlusion carries risk of death, adverse cardiovascular events

30 Oct 2023

Add-on high-dose cryoprecipitate of no benefit to patients with trauma, bleeding

24 Oct 2023

When added to standard care, early and empirical treatment with high-dose cryoprecipitate does not appear to improve clinical outcomes in patients with trauma and bleeding, according to the CRYOSTAT-2 study.

Add-on high-dose cryoprecipitate of no benefit to patients with trauma, bleeding

24 Oct 2023

Orthostatic hypotension ups risk of cerebral small vessel disease

24 Oct 2023

Delayed/prolonged orthostatic hypotension (DPOH) occurs more frequently than early orthostatic hypotension (EOH) among memory clinic patients, reveals a study.

Orthostatic hypotension ups risk of cerebral small vessel disease

24 Oct 2023

BP control, antihypertensive drug use prevent death after stroke

23 Oct 2023

Ischaemic stroke (IS) patients with consistently controlled blood pressure (BP) and who regularly take antihypertensive medications following discharge have lower risks of death and vascular events, reports a recent study.

BP control, antihypertensive drug use prevent death after stroke

23 Oct 2023

Cardiac autonomic neuropathy a risk factor for silent myocardial infarction

23 Oct 2023

Individuals with cardiac autonomic neuropathy appear to be at increased risk of incident silent myocardial infarction (SMI), regardless of the presence of traditional atherosclerotic risk factors, according to a study.

Cardiac autonomic neuropathy a risk factor for silent myocardial infarction

23 Oct 2023

News & Updates

Filter by Specialty:

Specialty:

Lower chance of new stroke with ticagrelor vs clopidogrel in patients without ICAS

Lower chance of new stroke with ticagrelor vs clopidogrel in patients without ICAS

Survey reveals an overview of patient experience with pDPN

Survey reveals an overview of patient experience with pDPN

Brexpiprazole improves agitation in Alzheimer’s dementia

Brexpiprazole improves agitation in Alzheimer’s dementia

Brain-controlled ankle prosthesis promotes natural movement, stability

Brain-controlled ankle prosthesis promotes natural movement, stability

Original New Drug Application Approvals by US FDA (16-31 October 2023)

Original New Drug Application Approvals by US FDA (16-31 October 2023)

Retinal artery occlusion carries risk of death, adverse cardiovascular events

Retinal artery occlusion carries risk of death, adverse cardiovascular events

Add-on high-dose cryoprecipitate of no benefit to patients with trauma, bleeding

Add-on high-dose cryoprecipitate of no benefit to patients with trauma, bleeding

Orthostatic hypotension ups risk of cerebral small vessel disease

Orthostatic hypotension ups risk of cerebral small vessel disease

BP control, antihypertensive drug use prevent death after stroke

BP control, antihypertensive drug use prevent death after stroke

Cardiac autonomic neuropathy a risk factor for silent myocardial infarction

Cardiac autonomic neuropathy a risk factor for silent myocardial infarction